Koesten Hirschmann & Crabtree’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-60
Closed -$11.1K 143
2025
Q3
$11.1K Sell
60
-47
-44% -$8.05K 0.01% 136
2025
Q2
$16.3K Buy
107
+47
+78% +$7.22K 0.01% 124
2025
Q1
$9.95K Hold
60
0.01% 133
2024
Q4
$8.68K Hold
60
0.01% 132
2024
Q3
$9.72K Hold
60
0.01% 124
2024
Q2
$9.49K Hold
60
0.01% 137
2024
Q1
$9.49K Hold
60
0.01% 137
2023
Q4
$9.4K Hold
60
0.01% 122
2023
Q3
$9.35K Sell
60
-7
-10% -$1.16K 0.01% 105
2023
Q2
$11.1K Hold
67
0.01% 96
2023
Q1
$10.4K Hold
67
0.01% 107
2022
Q4
$11.8K Buy
+67
New +$11.6K 0.01% 100

Other funds holding JNJ

Koesten Hirschmann & Crabtree's JNJ Position: Q4 2025 in Review

Koesten Hirschmann & Crabtree sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 60 shares — an estimated $11.1K sold.

Koesten Hirschmann & Crabtree first reported a position in JNJ in Q4 2022 and held it in 12 quarters. The position peaked at $16.3K in Q2 2025. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Koesten Hirschmann & Crabtree reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
  • Koesten Hirschmann & Crabtree sold 60 Johnson & Johnson shares in Q4 2025, an estimated $11.1K.
  • Koesten Hirschmann & Crabtree first reported a position in Johnson & Johnson in Q4 2022 and held it in 12 quarters.
  • Koesten Hirschmann & Crabtree's Johnson & Johnson position peaked at $16.3K in Q2 2025.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q4 2025, filed 9 Feb 2026.